Current Edition

companies

Moderna CFO Meline steps down $42 million richer, passing reins to incoming finance chief Gomez

Coming out of retirement to work for Moderna as its chief financial officer was a sweet deal for David Meline. In fact, it will make …

Continue Reading →
Asia

Using sumo ads, Moderna makes a heavy marketing push in Japan to rebuild trust in its COVID-19 vaccine

When some Moderna COVID-19 vaccine vials were found to be contaminated with metallic shards last year in Japan, the company suffered a reputation crisis in …

Continue Reading →
children

Moderna seeks FDA nod for COVID vaccine in children under 6, starts delayed filing for older kids

Moderna has new data backing the use of its COVID-19 vaccine Spikevax at a low dose in the youngest children under the age of 6, …

Continue Reading →
BioNTech

Moderna, Regeneron warn about the effectiveness of COVID-19 drugs, vaccines against the omicron variant

As the world assesses the threat posed by the COVID-19 omicron variant, two top companies producing pandemic drugs and vaccines have warned that their current …

Continue Reading →
AstraZeneca

AstraZeneca CEO questions mRNA vaccine superiority, raising theory that his company’s shot offers longer-lasting protection

AstraZeneca’s chief executive Pascal Soriot is challenging the notion that his company’s vaccine is inferior to the mRNA vaccines from Moderna and Pfizer. In fact, …

Continue Reading →
COVID-19

Johnson & Johnson wins FDA panel backing for a second dose of its COVID shot but don’t call it a ‘booster’

Over the last year, the Johnson & Johnson COVID-19 vaccine has been commonly referred to as a single-shot alternative to the two-dose regimens of mRNA …

Continue Reading →
COVID-19

Pfizer, Moderna will rake in a combined $93 billion next year on COVID-19 vaccine sales

If you think Pfizer-BioNTech and Moderna are making a fortune on COVID-19 vaccine sales this year, just wait for 2022. The messenger RNA shot producers …

Continue Reading →
COVID-19

FDA delays decision on Moderna’s COVID-19 vaccine in 12-17 age group because of myocarditis concerns

After reports in four Nordic countries of the heart inflammation condition myocarditis, the FDA has delayed a decision on the Moderna COVID-19 shot for kids …

Continue Reading →
COVID-19

Researchers retract preprint study that miscalculated higher heart inflammation risk for Moderna, Pfizer COVID vaccines

In the past few weeks, anti-vaxxers have rallied behind a nonpeer-reviewed study by a group of Canadian researchers as evidence against COVID-19 vaccines. Turns out, …

Continue Reading →
COVID-19

After Moderna contamination mess, Takeda strikes deal with Japan to supply Novavax COVID-19 vaccines

As Moderna faces questions about contaminants found in its COVID-19 vaccines in Japan, the company’s distribution partner in the country, Takeda, is moving forward on …

Continue Reading →